Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Alzheimer's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04828434
What this trial is testing

Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study

Who this might be right for
DementiaDementia, VascularDementia, Mixed+8 more
University College, London 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06840054
What this trial is testing

The Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Tabriz University of Medical Sciences 30
Large-scale testing (Phase 3)Ended earlyNCT04886063
What this trial is testing

Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
LeonaBio 423
Large-scale testing (Phase 3)Ended earlyNCT01524887
What this trial is testing

Phase 3 IGIV, 10% in Alzheimer´s Disease

Who this might be right for
Alzheimer´s Disease
Baxalta now part of Shire 508
Large-scale testing (Phase 3)Ended earlyNCT00667810
What this trial is testing

Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients

Who this might be right for
Alzheimer Disease
Pfizer 901
Testing effectiveness (Phase 2)Looking for participantsNCT07367815
What this trial is testing

Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease

Who this might be right for
Alzheimer Disease
University Hospital, Toulouse 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04639050
What this trial is testing

Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 241
Not applicableNot Yet RecruitingNCT05575271
What this trial is testing

Implantable Vagus Nerve Stimulation Modulation of Coeruleus-Norepinephrine Network for Mild-Moderate AD Patients

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 6
Testing effectiveness (Phase 2)Study completedNCT02907567
What this trial is testing

Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Cognition Therapeutics 19
Testing effectiveness (Phase 2)Study completedNCT05811442
What this trial is testing

Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Beijing Joekai Biotechnology LLC 68
Not applicableStudy completedNCT01089582
What this trial is testing

Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets

Who this might be right for
Alzheimer Disease
Pfizer 628
Large-scale testing (Phase 3)Study completedNCT00231946
What this trial is testing

ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)

Who this might be right for
Alzheimer's Disease
Voyager Pharmaceutical Corporation 555
Early research (Phase 1)Study completedNCT01837641
What this trial is testing

LY3002813 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 63
Large-scale testing (Phase 3)UnknownNCT00088673
What this trial is testing

Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Bellus Health Inc. - a GSK company 950
Large-scale testing (Phase 3)UnknownNCT04229927
What this trial is testing

BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease

Who this might be right for
Moderate-to-severe Alzheimer's Disease
Hyundai Pharmaceutical Co., LTD. 712
Post-approval studies (Phase 4)UnknownNCT05430867
What this trial is testing

Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
TreatmentEfficacySafety+1 more
First Affiliated Hospital Xi'an Jiaotong University 150
Testing effectiveness (Phase 2)Study completedNCT00959192
What this trial is testing

Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 32
Post-approval studies (Phase 4)Looking for participantsNCT05908695
What this trial is testing

An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 1,312
Large-scale testing (Phase 3)Study completedNCT00097916
What this trial is testing

An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Forest Laboratories 34
Testing effectiveness (Phase 2)Study completedNCT01527916
What this trial is testing

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 438
Next Page